Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,724 | 182 | 99.7% |
| Education | $8.74 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $623.13 | 40 | $0 (2024) |
| PFIZER INC. | $569.81 | 44 | $0 (2024) |
| Novo Nordisk Inc | $315.47 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $297.36 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $163.10 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $123.71 | 9 | $0 (2021) |
| GlaxoSmithKline, LLC. | $100.31 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $87.27 | 6 | $0 (2022) |
| Allergan Inc. | $76.17 | 6 | $0 (2019) |
| ABBVIE INC. | $61.53 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $414.98 | 23 | Novartis Pharmaceuticals Corporation ($175.61) |
| 2023 | $352.37 | 26 | Novartis Pharmaceuticals Corporation ($145.49) |
| 2022 | $215.55 | 15 | PFIZER INC. ($86.90) |
| 2021 | $196.46 | 14 | Novo Nordisk Inc ($66.43) |
| 2020 | $132.64 | 9 | Novo Nordisk Inc ($34.82) |
| 2019 | $245.87 | 16 | Novartis Pharmaceuticals Corporation ($132.57) |
| 2018 | $198.77 | 15 | Allergan Inc. ($48.31) |
| 2017 | $976.33 | 65 | PFIZER INC. ($288.66) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.54 | General |
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.46 | General |
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 07/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $11.18 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $42.45 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.37 | General |
| 01/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 426 | 630 | $121,326 | $32,753 |
| 2022 | 8 | 363 | 491 | $91,058 | $24,779 |
| 2021 | 8 | 377 | 499 | $93,507 | $26,955 |
| 2020 | 8 | 380 | 497 | $81,125 | $21,089 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 81 | 182 | $29,114 | $6,527 | 22.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 101 | $17,339 | $5,865 | 33.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 61 | $20,141 | $5,537 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 97 | 120 | $18,380 | $5,328 | 29.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 80 | 84 | $18,175 | $4,880 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 55 | 64 | $14,002 | $3,553 | 25.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 18 | $4,175 | $1,063 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 87 | 107 | $23,326 | $6,220 | 26.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 40 | 40 | $12,854 | $4,083 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 75 | 90 | $13,680 | $4,002 | 29.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 53 | 116 | $16,902 | $3,450 | 20.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 61 | $10,215 | $3,351 | 32.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 37 | 38 | $7,990 | $2,097 | 26.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 20 | 20 | $4,210 | $1,100 | 26.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 18 | 19 | $1,881 | $476.97 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 138 | 177 | $38,586 | $10,272 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 77 | 91 | $13,832 | $4,101 | 29.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 62 | $10,142 | $3,450 | 34.0% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 28 | 28 | $8,820 | $2,910 | 33.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 34 | 77 | $8,497 | $2,293 | 27.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 19 | $5,980 | $1,998 | 33.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 30 | 30 | $6,165 | $1,670 | 27.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 15 | 15 | $1,485 | $262.71 | 17.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 171 | 219 | $33,288 | $7,276 | 21.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 63 | $10,269 | $3,580 | 34.9% |
About Dr. Frank Moskos, M.D
Dr. Frank Moskos, M.D is a Family Medicine healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356543193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Moskos, M.D has received a total of $2,733 in payments from pharmaceutical and medical device companies, with $414.98 received in 2024. These payments were reported across 183 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,724).
As a Medicare-enrolled provider, Moskos has provided services to 1,546 Medicare beneficiaries, totaling 2,117 services with total Medicare billing of $105,576. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Florence, SC
- Active Since 06/04/2007
- Last Updated 10/27/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356543193
Products in Payments
- ENTRESTO (Drug) $418.77
- ELIQUIS (Drug) $320.29
- LEQVIO (Drug) $185.75
- EUCRISA (Drug) $175.52
- XARELTO (Drug) $163.10
- Ozempic (Drug) $158.28
- SOLIQUA (Drug) $144.59
- TOUJEO (Drug) $90.24
- LYRICA (Drug) $54.04
- TEFLARO (Drug) $51.49
- Rybelsus (Drug) $48.86
- FARXIGA (Drug) $47.29
- ANORO (Drug) $45.89
- TZIELD (Biological) $42.45
- Victoza (Drug) $34.02
- JARDIANCE (Drug) $26.15
- BREO (Drug) $25.26
- Barostim Neo System (Device) $25.24
- DALVANCE (Drug) $24.68
- BEVESPI AEROSPHERE (Drug) $24.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Florence
Dr. Bradley Gray
Family Medicine — Payments: $23,764
Cory Smith, Md, MD
Family Medicine — Payments: $16,619
Donald Behling, Md, MD
Family Medicine — Payments: $16,401
Clarence Alexander, Md, MD
Family Medicine — Payments: $15,630
Dr. Guy Mcclary, Md, MD
Family Medicine — Payments: $15,201
Dr. Edward Schumann, Md, MD
Family Medicine — Payments: $14,923